The FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommended the approval of a cancer vaccine on May 18. The drug, Gardasil, which is manufactured by Merck, will fight against four strands of the human papilloma virus (HPV) that has been linked to cervical cancer.
Gardasil is the first vaccine to fight cancer. The FDA is set to vote on approval on June 8. Although not required to take the advisory panel's recommendation, the FDA usually does.
The drug ...